Researchers recently enhanced the titer of a cell line still in development to produce adenovirus viral vectors by 7.5-fold, and without the risk of also producing replication-competent adenoviruses ...

In the race to bring new biologics to market, development teams are constantly balancing speed, quality, and regulatory ...

This article is based on a poster originally authored by Julia Scherzinger, Daniel Türk, and Fernando Aprile-Garcia from CYTENA GmbH. There is constant pressure to reduce timelines in mammalian cell ...

Rumors indicate that Tesla might start in-house production of LFP cells in Nevada using equipment and technology from CATL. A new report about a lithium carbonate supply deal seems to confirm this ...

Tufts University and the Good Food Institute are salvaging cell lines from failed startups to accelerate scalable cultivated ...

CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.